GET 15% OFF WHEN YOU START A RECURRING ORDER! USE CODE "START" IN CHECKOUT. CANCEL ANYTIME!

GINKGO BILOBA LEAF EXTRACT (24% GLYCOSIDES) BENEFITS

KEY BENEFITS OF GINKGO BILOBA

    • Supports mood
    • Supports neuroprotection
    • Supports vascular function
    • Supports brain health and cognitive performance

ABOUT GINKGO BILOBA

One of the most widely used and researched herbs for the brain is Ginkgo biloba. Traditional Chinese Medicine has used ginkgo biloba for several hundred years. The use of standardized Ginkgo biloba extracts dates back to the mid-1960s.

 

As the only surviving species of the order Ginkgoales that existed on earth 190 million years ago, the Ginkgo biloba tree is a living fossil native to China. Some specimens of the trees are believed to be as old as 1,500 years.

 

Some of its bioactive ingredients include flavonoid glycosides such as quercetin, kaempferol, and isorhamnetin, as well as substances known as terpene lactones such as ginkgolides A, B, and C, and bilobalide. These compounds in Ginkgo are responsible for supporting multiple neurotransmitter systems, supporting neurogenesis, as well as supporting healthy vascular function and cerebral blood flow.

 

One of the best-known effects of Ginkgo Biloba is its ability to promote attention, concentration, memory, and mood.


GINKGO BILOBA FULL BENEFITS

Brain and cognitive function

 

  • Supports memory [2–6]
  • Supports working memory [3,7,8]
  • Supports attention [9,10]
  • Supports information processing speed [7,11]
  • Supports executive function [7]
  • Supports cognitive health [12–14]
  • Supports healthy cerebral blood flow [15–17]
  • Supports acetylcholine levels [18]
  • Influences anticholinesterase activity [19]
  • Supports dopamine levels [20,21]
  • Supports noradrenaline levels [20]
  • Supports serotonergic neurotransmission [22–24]
  • Supports neurogenesis [25–27]
  • Supports synaptogenesis [25]
  • Supports brain-derived neurotrophic factor (BDNF) [24,25,28,29]
  • Supports cyclic-AMP response element binding protein (CREB) activity [26]
  • Supports neuronal membrane fluidity [30]
  • Supports neuroprotective functions [31–35]

 

Mood and stress response

 

  • Supports a calm mood and positive affect [24,36–39]
  • Supports healthy stress responses and stress hormone levels (adaptogenic) [40,41]
  • Modulates the hypothalamic-pituitary-adrenal (HPA) axis [42]

 

Vascular health

 

  • Supports healthy blood flow [43–46]
  • Supports endothelial function [47–51]
  • Supports vascular function [52–54]
  • Influences platelet-activating factor (PAF) activity [55–57]
  • Supports blood antioxidant capacity [29]

 

Healthy aging and longevity

 

  • Supports antioxidant defenses [22–24]
  • Counters ROS production and oxidative stress [22–25]
  • Supports free radical scavenging [25,26]
  • Supports mitochondrial function [47,50,58–60]
  • Supports mitochondrial responses to age-related oxidative stress [61]

 

Complementary ingredients

 

  • Ginger for mood support [62–65]
  • Ginseng for cognitive performance [66–71]
  • Rhodiola for cognitive performance [72]

GINKGO BILOBA LEAF CAN BE FOUND IN:

Morning Momentum

Get Instant Access To A Simple, Proven System That Has Helped

THOUSANDS of People

IGNITE Their Health and Energy

to Create The Life They Deserve!

Learn More


REFERENCES

[1]F.V. DeFeudis, Pharmacopsychiatry 36 Suppl 1 (2003) S2–7.
[2]D.O. Kennedy, P.A. Jackson, C.F. Haskell, A.B. Scholey, Hum. Psychopharmacol. 22 (2007) 559–566.
[3]U. Rigney, S. Kimber, I. Hindmarch, Phytother. Res. 13 (1999) 408–415.
[4]R. Kaschel, Phytomedicine 18 (2011) 1202–1207.
[5]Z. Subhan, I. Hindmarch, Int. J. Clin. Pharmacol. Res. 4 (1984) 89–93.
[6]J.A. Mix, W.D. Crews Jr, Hum. Psychopharmacol. 17 (2002) 267–277.
[7]C. Stough, J. Clarke, J. Lloyd, P.J. Nathan, Int. J. Neuropsychopharmacol. 4 (2001) 131–134.
[8]R.B. Silberstein, A. Pipingas, J. Song, D.A. Camfield, P.J. Nathan, C. Stough, Evid. Based. Complement. Alternat. Med. 2011 (2011) 164139.
[9]D.O. Kennedy, A.B. Scholey, K.A. Wesnes, Psychopharmacology 151 (2000) 416–423.
[10]S. Elsabagh, D.E. Hartley, O. Ali, E.M. Williamson, S.E. File, Psychopharmacology 179 (2005) 437–446.
[11]J.A. Mix, W.D. Crews Jr, J. Altern. Complement. Med. 6 (2000) 219–229.
[12]P.L. Le Bars, M.M. Katz, N. Berman, T.M. Itil, A.M. Freedman, A.F. Schatzberg, JAMA 278 (1997) 1327–1332.
[13]O. Napryeyenko, I. Borzenko, GINDEM-NP Study Group, Arzneimittelforschung 57 (2007) 4–11.
[14]R. Ihl, M. Tribanek, N. Bachinskaya, GOTADAY Study Group, Pharmacopsychiatry 45 (2012) 41–46.
[15]N. Kamkaew, C. Norman Scholfield, K. Ingkaninan, N. Taepavarapruk, K. Chootip, Phytother. Res. 27 (2013) 135–138.
[16]A. Mashayekh, D.L. Pham, D.M. Yousem, M. Dizon, P.B. Barker, D.D.M. Lin, Neuroradiology 53 (2011) 185–191.
[17]R.F. Santos, J.C. Galduróz, A. Barbieri, M.L. Castiglioni, L.Y. Ytaya, O.F. Bueno, Pharmacopsychiatry 36 (2003) 127–133.
[18]J. Kehr, S. Yoshitake, S. Ijiri, E. Koch, M. Nöldner, T. Yoshitake, Int. Psychogeriatr. 24 Suppl 1 (2012) S25–34.
[19]A. Das, G. Shanker, C. Nath, R. Pal, S. Singh, H. Singh, Pharmacol. Biochem. Behav. 73 (2002) 893–900.
[20]T. Yoshitake, S. Yoshitake, J. Kehr, Br. J. Pharmacol. 159 (2010) 659–668.
[21]K.-Y. Yeh, C.-H. Wu, M.-Y. Tai, Y.-F. Tsai, Neuroscience 189 (2011) 199–206.
[22]F. Huguet, K. Drieu, A. Piriou, J. Pharm. Pharmacol. 46 (1994) 316–318.
[23]F. Bolaños-Jiménez, R. Manhães de Castro, H. Sarhan, N. Prudhomme, K. Drieu, G. Fillion, Fundam. Clin. Pharmacol. 9 (1995) 169–174.
[24]Z.-H. Liang, Y.-B. Jia, M.-L. Wang, Z.-R. Li, M. Li, Y.-L. Yun, R.-X. Zhu, Neuropsychiatr. Dis. Treat. 15 (2019) 2551–2557.
[25]F. Tchantchou, P.N. Lacor, Z. Cao, L. Lao, Y. Hou, C. Cui, W.L. Klein, Y. Luo, J. Alzheimers. Dis. 18 (2009) 787–798.
[26]F. Tchantchou, Y. Xu, Y. Wu, Y. Christen, Y. Luo, FASEB J. 21 (2007) 2400–2408.
[27]G.-H. Jin, Z. Huang, X.-F. Tan, M.-L. Tian, X.-H. Zhang, J.-B. Qin, H.-J. Xu, D.T. Yew, Y.T. Mak, Cell Biol. Int. 30 (2006) 500–504.
[28]X.Y. Zhang, W.-F. Zhang, D.-F. Zhou, D.C. Chen, M.H. Xiu, H.-R. Wu, C.N. Haile, T.A. Kosten, T.R. Kosten, Biol. Psychiatry 72 (2012) 700–706.
[29]E. Sadowska-Krępa, B. Kłapcińska, I. Pokora, P. Domaszewski, K. Kempa, T. Podgórski, Nutrients 9 (2017).
[30]C. Ramassamy, F. Girbe, Y. Christen, J. Costentin, Free Radic. Res. Commun. 19 (1993) 341–350.
[31]M. Jahanshahi, E.G. Nickmahzar, F. Babakordi, Anat. Sci. Int. 88 (2013) 217–222.
[32]M. Jahanshahi, E. Nikmahzar, N. Yadollahi, K. Ramazani, Anat. Cell Biol. 45 (2012) 92–96.
[33]E.-J. Lee, H.-Y. Chen, T.-S. Wu, T.-Y. Chen, I.A. Ayoub, K.I. Maynard, J. Neurosci. Res. 68 (2002) 636–645.
[34]S. Saleem, H. Zhuang, S. Biswal, Y. Christen, S. Doré, Stroke 39 (2008) 3389–3396.
[35]L. Zhu, J. Wu, H. Liao, J. Gao, X.N. Zhao, Z.X. Zhang, Zhongguo Yao Li Xue Bao 18 (1997) 344–347.
[36]H. Woelk, K.H. Arnoldt, M. Kieser, R. Hoerr, J. Psychiatr. Res. 41 (2007) 472–480.
[37]R. Hoerr, Pharmacopsychiatry 36 Suppl 1 (2003) S56–61.
[38]P. Rojas, N. Serrano-García, O.N. Medina-Campos, J. Pedraza-Chaverri, S.O. Ogren, C. Rojas, Neurochem. Int. 59 (2011) 628–636.
[39]C.-X. Dai, C.-C. Hu, Y.-S. Shang, J. Xie, Medicine 97 (2018) e12421.
[40]J.R. Rapin, I. Lamproglou, K. Drieu, F.V. Defeudis, General Pharmacology: The Vascular System 25 (1994) 1009–1016.
[41]D. Jezova, R. Duncko, M. Lassanova, M. Kriska, F. Moncek, J. Physiol. Pharmacol. 53 (2002) 337–348.
[42]A. Marcilhac, N. Dakine, N. Bourhim, V. Guillaume, M. Grino, K. Drieu, C. Oliver, Life Sci. 62 (1998) 2329–2340.
[43]J. Mehlsen, H. Drabaek, N. Wiinberg, K. Winther, Clin. Physiol. Funct. Imaging 22 (2002) 375–378.
[44]E. Boelsma, R.-J.A.N. Lamers, H.F.J. Hendriks, J.H.J. van Nesselrooij, L. Roza, Planta Med. 70 (2004) 1052–1057.
[45]Y.-Z. Wu, S.-Q. Li, X.-G. Zu, J. Du, F.-F. Wang, Phytother. Res. 22 (2008) 734–739.
[46]Y. Wu, S. Li, W. Cui, X. Zu, J. Du, F. Wang, Phytomedicine 15 (2008) 164–169.
[47]H.-C. Ou, W.-J. Lee, I.-T. Lee, T.-H. Chiu, K.-L. Tsai, C.-Y. Lin, W.H.-H. Sheu, J. Appl. Physiol. 106 (2009) 1674–1685.
[48]H.-C. Ou, Y.-L. Hsieh, N.-C. Yang, K.-L. Tsai, K.-L. Chen, C.-S. Tsai, I.-J. Chen, B.-T. Wu, S.-D. Lee, J. Appl. Physiol. 114 (2013) 274–285.
[49]S.V. Pierre, P. Lesnik, M. Moreau, L. Bonello, M.-T. Droy-Lefaix, S. Sennoune, M.-J. Duran, T.A. Pressley, J. Sampol, J. Chapman, J.-M. Maixent, Cell. Mol. Biol. 54 Suppl (2008) OL1032–42.
[50]D. Janssens, C. Michiels, E. Delaive, F. Eliaers, K. Drieu, J. Remacle, Biochem. Pharmacol. 50 (1995) 991–999.
[51]C. Zhang, D.-F. Wang, Z. Zhang, D. Han, K. Yang, J. Microbiol. Biotechnol. 27 (2017) 584–590.
[52]M. Rodríguez, L. Ringstad, P. Schäfer, S. Just, H.W. Hofer, M. Malmsten, G. Siegel, Atherosclerosis 192 (2007) 438–444.
[53]J.-Y. Tsai, K.-H. Su, S.-K. Shyue, Y.R. Kou, Y.-B. Yu, S.-H. Hsiao, A.-N. Chiang, Y.-L. Wu, L.-C. Ching, T.-S. Lee, Cardiovasc. Res. 88 (2010) 415–423.
[54]J. Tian, Y. Liu, K. Chen, Curr. Vasc. Pharmacol. 15 (2017) 532–548.
[55]E. Koch, Phytomedicine 12 (2005) 10–16.
[56]M. Akisü, N. Kültürsay, I. Coker, A. Hüseyinov, Biol. Neonate 74 (1998) 439–444.
[57]H.-J. Liao, Y.-F. Zheng, H.-Y. Li, G.-P. Peng, Planta Med. 77 (2011) 1818–1821.
[58]A. Eckert, U. Keil, S. Kressmann, K. Schindowski, S. Leutner, S. Leutz, W.E. Müller, Pharmacopsychiatry 36 Suppl 1 (2003) S15–23.
[59]D. Janssens, J. Remacle, K. Drieu, C. Michiels, Biochem. Pharmacol. 58 (1999) 109–119.
[60]G. Du, K. Willet, A. Mouithys-Mickalad, C.M. Sluse-Goffart, M.T. Droy-Lefaix, F.E. Sluse, Free Radic. Biol. Med. 27 (1999) 596–604.
[61]J. Sastre, A. Millán, J. García de la Asunción, R. Plá, G. Juan, Pallardó, E. O’Connor, J.A. Martin, M.T. Droy-Lefaix, J. Viña, Free Radic. Biol. Med. 24 (1998) 298–304.
[62]R.U. Hasenöhrl, C.H. Nichau, C.H. Frisch, M.A. De Souza Silva, J.P. Huston, C.M. Mattern, R. Häcker, Pharmacol. Biochem. Behav. 53 (1996) 271–275.
[63]R.U. Hasenöhrl, B. Topic, C. Frisch, R. Häcker, C.M. Mattern, J.P. Huston, Pharmacol. Biochem. Behav. 59 (1998) 527–535.
[64]B. Topic, R.U. Hasenöhrl, R. Häcker, J.P. Huston, Phytother. Res. 16 (2002) 312–315.
[65]B. Topic, E. Tani, K. Tsiakitzis, P.N. Kourounakis, E. Dere, R.U. Hasenöhrl, R. Häcker, C.M. Mattern, J.P. Huston, Neurobiol. Aging 23 (2002) 135–143.
[66]K.A. Wesnes, T. Ward, A. McGinty, O. Petrini, Psychopharmacology 152 (2000) 353–361.
[67]A.B. Scholey, D.O. Kennedy, Hum. Psychopharmacol. 17 (2002) 35–44.
[68]D.O. Kennedy, A.B. Scholey, K.A. Wesnes, Physiol. Behav. 75 (2002) 739–751.
[69]K.A. Wesnes, R.A. Faleni, N.R. Hefting, G. Hoogsteen, J.J. Houben, E. Jenkins, J.H. Jonkman, J. Leonard, O. Petrini, J.J. van Lier, Psychopharmacol. Bull. 33 (1997) 677–683.
[70]G.Z. Steiner, A. Yeung, J.-X. Liu, D.A. Camfield, F.M. de Blasio, A. Pipingas, A.B. Scholey, C. Stough, D.H. Chang, BMC Complement. Altern. Med. 16 (2016) 15.
[71]M. Yakoot, A. Salem, S. Helmy, Clin. Interv. Aging 8 (2013) 975–981.
[72]H.M. Al-Kuraishy, J Intercult Ethnopharmacol 5 (2016) 7–13.